LNSR — LENSAR, Inc.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1320350 ·
Last close
$4.91
Market Cap
$60.36M
52W High
$12.94
52W Low
$4.30
ADV30
63,485
Next earnings
2026-11-10
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | — | — | — | — | — | — | — |
| Jun 2026 | 16,495,000 | 9,776,000 | 2,134,000 | 3,535,000 | 69,558,000 | 13,565,000 | 54,653,000 |
| Mar 2026 | 13,428,000 | 6,382,000 | 2,239,000 | 36,332,000 | 66,223,000 | 12,494,000 | 55,433,000 |
| Dec 2025 | 16,025,000 | 6,937,000 | -4,919,000 | -1,458,000 | 71,430,000 | 12,974,000 | 97,449,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-4,646,000
Investing CF
$9,098,000
Financing CF
$533,000
CapEx
$-195,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.40
As of
2026-11-15
Balance + Analyst (yfinance extras)
Retained Earnings
$-142,431,000
Inventory
$25,141,000
Receivables
$5,623,000
ST Investments
$0
EBIT TTM
$-1,979,000
Pretax Income TTM
$33,686,000
Interest Exp TTM
—
Analysts
3
Yahoo Snapshot (yfinance, live)
Total Revenue
$60,079,000
EBITDA
$2,504,000
Free Cash Flow
$-14,082,875
Enterprise Value
$64,819,204
Total Cash
$12,622,000
Total Debt
$2,186,000
Shares Out
12,294,241
Trailing EPS
$0.44
Book Value
$0.90
ROE
529.3%
ROA
-1.8%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 58,435,000 | -24,578,000 | -34,280,000 | 71,430,000 | 97,449,000 | -26,019,000 | -14,831,000 |
| Dec 2024 | 53,494,000 | -6,936,000 | -31,404,000 | 66,297,000 | 61,435,000 | 4,862,000 | -2,275,000 |
| Dec 2023 | 42,164,000 | -12,229,000 | -14,383,000 | 69,585,000 | 36,156,000 | 33,429,000 | -9,659,000 |
| Dec 2022 | 35,358,000 | -20,177,000 | -19,914,000 | 55,844,000 | 13,860,000 | 41,984,000 | -14,856,000 |
TTM Snapshot
Revenues TTM
$60,264,000
NetIncome TTM
$34,696,000
OpCashFlow TTM
—
Assets (Latest)
$69,558,000
Forward EPS
$-0.85
Max Pain — expiry 2027-01-15 (volume-derived — Yahoo OI feed degraded)
max pain strike: $5.00 · spot: $4.85 · call volume: 205 · put volume: 5
Expected Move to 2027-01-15:
±$0.95
(19.59%) —
implied range
$3.90 –
$5.80
· ATM straddle on $5.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| QTEX | QTREX Quantum Ltd. | $60.72M | $1.09 | — |
| OM | Outset Medical, Inc. | $59.64M | $3.16 | — |
| MDNC | Medinotec Inc. | $58.78M | $5.00 | — |
| CNXU | Conexeu Sciences Inc. | $56.41M | $2.00 | — |
| POSC | POSITRON CORP | $55.84M | $1.70 | — |
News headlines (Yahoo Finance, 1h cache)
LENSAR Inc (LNSR) (Q3 2026) Earnings Call Highlights: Recurring Revenue Surges 17% as Margins ...
2026-11-10 21:07 · Yahoo
LENSAR (LNSR) Q3 2026 Earnings Call Transcript
2026-11-10 19:53 · Yahoo
LENSAR, Inc. Q3 2026 Earnings Call Summary
2026-11-10 17:57 · Yahoo
LENSAR® Reports Third Quarter 2026 Financial Results and Provides Business Update
2026-11-10 12:00 · Yahoo
LENSAR® to Report Third Quarter 2026 Results on November 10th, 2026
2026-11-03 13:00 · Yahoo
LENSAR (LNSR) Q2 2026 Earnings Call Transcript
2026-08-20 14:13 · Yahoo
LENSAR Inc (LNSR) (Q2 2026) Earnings Call Highlights: Record Revenue and Profitability Surge
2026-08-13 23:07 · Yahoo
LENSAR Q2 Earnings Call Highlights
2026-08-13 17:04 · Yahoo
LENSAR® Reports Second Quarter 2026 Results and Provides Business Update
2026-08-13 11:00 · Yahoo
LENSAR® to Report Second Quarter 2026 Results on August 13th, 2026
2026-08-06 12:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.